Monoclonal antibodies to HLA--DRw determinants.

Two monoclonal antibodies recognizing HLA-DRw (human la) antigens were produced. The DA2 antibody binds a monomorphic determinant, common to all specificities and Genox3.53 antibody binds to a cross-reacting site on the HLA-DRw1,2 and 6 specificities. Both antibodies are IgG1 and show complement dep...

Full description

Bibliographic Details
Main Authors: Brodsky, F, Parham, P, Bodmer, W
Format: Journal article
Language:English
Published: 1980
_version_ 1797087007319523328
author Brodsky, F
Parham, P
Bodmer, W
author_facet Brodsky, F
Parham, P
Bodmer, W
author_sort Brodsky, F
collection OXFORD
description Two monoclonal antibodies recognizing HLA-DRw (human la) antigens were produced. The DA2 antibody binds a monomorphic determinant, common to all specificities and Genox3.53 antibody binds to a cross-reacting site on the HLA-DRw1,2 and 6 specificities. Both antibodies are IgG1 and show complement dependent cytotoxicity only in the presence of rabbit anti-mouse IgG serum. Specificity of both antibodies for the HLA-DRw molecule was shown by inhibition of antibody binding by preincubation of antibody with detergent solubilized Ia from JY (HLA-DRw4,6) cells and by preincubation of target cells with F(ab')2 fragments of a rabbit anti-la serum. DA2 antibody reacted with all cells of human B cell origin tested and with peripheral blood lymphocytes of several primate species tested. Genox3.53 antibody bound only to human cells expressing HLA-DRw1,2 or 6 antigens, giving a negative reaction with all primates tested. Genox3.53 antibody detected a split in the HLA-DRw6 specificity, showing reduced binding to the Daudi cell (HLA-DRw6) in comparison with binding to several other cell lines typed as HLA-DRw6, under saturating conditions. This low reactivity with Daudi was confirmed by absorption experiments. The ratio of DA2 binding to Genox3.53 binding to homozygous and heterozygous cell lines under saturation conditions was compared. Results suggested that, on some cell lines, DA2 might be reacting with a second population of human Ia antigens in addition to the HLA-DRw antigens. When a mixture of saturating concentrations of DA2 and Genox3.53 antibodies was tested for binding to cells under saturating conditions, the number of counts bound suggested the antibodies could bind simultaneously. Direct binding experiments showed that when each antibody was iodinated, its binding was not inhibited by preincubation with the other antibody, confirming that the DA2 and Genox3.53 determinants are distinct on the Ia molecule.
first_indexed 2024-03-07T02:30:00Z
format Journal article
id oxford-uuid:a6e9566d-f2e7-4553-9ad9-dc33bc8f9a5a
institution University of Oxford
language English
last_indexed 2024-03-07T02:30:00Z
publishDate 1980
record_format dspace
spelling oxford-uuid:a6e9566d-f2e7-4553-9ad9-dc33bc8f9a5a2022-03-27T02:50:46ZMonoclonal antibodies to HLA--DRw determinants.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a6e9566d-f2e7-4553-9ad9-dc33bc8f9a5aEnglishSymplectic Elements at Oxford1980Brodsky, FParham, PBodmer, WTwo monoclonal antibodies recognizing HLA-DRw (human la) antigens were produced. The DA2 antibody binds a monomorphic determinant, common to all specificities and Genox3.53 antibody binds to a cross-reacting site on the HLA-DRw1,2 and 6 specificities. Both antibodies are IgG1 and show complement dependent cytotoxicity only in the presence of rabbit anti-mouse IgG serum. Specificity of both antibodies for the HLA-DRw molecule was shown by inhibition of antibody binding by preincubation of antibody with detergent solubilized Ia from JY (HLA-DRw4,6) cells and by preincubation of target cells with F(ab')2 fragments of a rabbit anti-la serum. DA2 antibody reacted with all cells of human B cell origin tested and with peripheral blood lymphocytes of several primate species tested. Genox3.53 antibody bound only to human cells expressing HLA-DRw1,2 or 6 antigens, giving a negative reaction with all primates tested. Genox3.53 antibody detected a split in the HLA-DRw6 specificity, showing reduced binding to the Daudi cell (HLA-DRw6) in comparison with binding to several other cell lines typed as HLA-DRw6, under saturating conditions. This low reactivity with Daudi was confirmed by absorption experiments. The ratio of DA2 binding to Genox3.53 binding to homozygous and heterozygous cell lines under saturation conditions was compared. Results suggested that, on some cell lines, DA2 might be reacting with a second population of human Ia antigens in addition to the HLA-DRw antigens. When a mixture of saturating concentrations of DA2 and Genox3.53 antibodies was tested for binding to cells under saturating conditions, the number of counts bound suggested the antibodies could bind simultaneously. Direct binding experiments showed that when each antibody was iodinated, its binding was not inhibited by preincubation with the other antibody, confirming that the DA2 and Genox3.53 determinants are distinct on the Ia molecule.
spellingShingle Brodsky, F
Parham, P
Bodmer, W
Monoclonal antibodies to HLA--DRw determinants.
title Monoclonal antibodies to HLA--DRw determinants.
title_full Monoclonal antibodies to HLA--DRw determinants.
title_fullStr Monoclonal antibodies to HLA--DRw determinants.
title_full_unstemmed Monoclonal antibodies to HLA--DRw determinants.
title_short Monoclonal antibodies to HLA--DRw determinants.
title_sort monoclonal antibodies to hla drw determinants
work_keys_str_mv AT brodskyf monoclonalantibodiestohladrwdeterminants
AT parhamp monoclonalantibodiestohladrwdeterminants
AT bodmerw monoclonalantibodiestohladrwdeterminants